SecBot SecBot
Insider Cluster (3 insiders) ·Filed Jul 22, 2026

SGMT

Sagimet Biosciences Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed3mo ago
Insider cluster: 2 insiders, $222K total
Actionable Insight • Neutral

The cluster is modest in size relative to market cap and insider sales are generally weak predictors of future returns. Monitor for any upcoming clinical data readouts or financing events that could explain the concentrated selling. The CEO's sale is the most notable, but without a 10b5-1 plan disclosure or a material corporate event, this is likely routine portfolio diversification.

DirectionNeutral
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
SGMT ▲ +14.41% at T+60d
NEUTRAL call +14.41% · α vs SPY +11.01% · entry $7.01 → $8.02
Entry = T+0 close
Jul 22, 2026
via day close
T+1d
+0.86%
call +0.86% · α +0.75%
$7.07
settled 3mo ago
T+5d
+4.28%
call +4.28% · α +3.80%
$7.31
settled 3mo ago
T+20d
+45.22%
call +45.22% · α +41.91%
$10.18
settled 2mo ago
T+60d
+14.41%
call +14.41% · α +11.01%
$8.02
settled 12d ago

Price Chart

Loading chart...

Executive Summary

Three Sagimet insiders, including the CEO, sold a combined $719K in open-market sales over a 7-day window. The CEO's $497K sale is the largest, and the cluster represents ~0.16% of the $437M market cap — a modest but notable amount.

Key Financial Metrics

Direction
selling
Total Value
$719.0K
Insiders
3

Key Facts

  • CEO David Happel sold 64,051 shares for ~$497K on 2026-07-20
  • Director George Kemble sold 18,844 shares for ~$141K on 2026-07-20
  • Chief Legal Officer Elizabeth Rozek sold 10,545 shares for ~$82K on 2026-07-20
  • Total insider sales of $719K represent ~0.16% of $437M market cap
  • No insider buying in the cluster — all three trades are open-market sales

Financial Impact

Total insider sales of approximately $719K, representing 0.16% of market cap

insider ownership

Risk Factors

  • Insider sales may signal management's lack of confidence ahead of clinical data or financing
  • No insider buying to offset the selling — one-sided bearish signal if it escalates

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (18 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-SGMT-1784793752978
16 reports for SGMT
Performance horizon
60% Hit rate @ T+1 3 of 5 directional calls Went positive at some point 3 of 5 best @ T+5▲ +10.12%Sep 30, 2026
Filters
Rows
Reports for SGMT — sortable, filterable
TypeNow
Oct 22, 2026
5d ago
8-K
NEUTRAL ★ 4/10
$9.95 $9.58▼ −3.72%▼ −3.20%$10.42 (+4.72%)
Oct 7, 2026
19d ago
SC 13G
NEUTRAL ★ 4/10
$8.92 $8.93▲ +0.11%▼ −0.49%$10.42 (+16.82%)
Oct 1, 2026
26d ago
Press Release
BEARISH ★ 6/10
$9.14 $9.03▲ +1.20%▲ +1.88%$10.42 (−14.00%)
Sep 30, 2026
27d ago
Press Release
BEARISH ★ 6/10
$9.88 $9.37▲ +5.16%▲ +5.34%$10.42 (−5.47%)
Sep 30, 2026
27d ago
8-K
BULLISH ★ 6/10
$9.88 $9.37▼ −5.16%▼ −5.34%$10.42 (+5.47%)
Sep 22, 2026
5w ago
Institutional Cluster
BULLISH ★ 4/10
$11.09 $10.42▼ −6.04%▼ −5.32%$10.42 (−6.04%)
Aug 25, 2026
9w ago
Press Release
NEUTRAL ★ 4/10
$10.29 $10.86▲ +5.54%▲ +5.52%$10.42 (+1.26%)
Aug 11, 2026
11w ago
8-K
MIXED ★ 5/10
$9.52 $9.39▼ −1.37%▼ −1.62%$10.42 (+9.45%)
Aug 11, 2026
11w ago
Press Release
NEUTRAL ★ 5/10
$9.52 $9.39▼ −1.37%▼ −1.62%$10.42 (+9.45%)
Jul 22, 2026
13w ago
Insider Cluster
NEUTRAL ★ 4/10
$7.01 $7.07▲ +0.86%▲ +0.75%$10.42 (+48.64%)
Showing 10 of 16

US Market Status

Market Closed — Opens Wed (15h 36m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 23, 2026